GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (TSE:2160) » Definitions » Common Stock

GNI Group (TSE:2160) Common Stock : 円13,277 Mil (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is GNI Group Common Stock?

GNI Group's quarterly common stock increased from Jun. 2024 (円13,219 Mil) to Sep. 2024 (円13,224 Mil) and increased from Sep. 2024 (円13,224 Mil) to Dec. 2024 (円13,277 Mil).

GNI Group's annual common stock increased from Dec. 2022 (円10,893 Mil) to Dec. 2023 (円13,052 Mil) and increased from Dec. 2023 (円13,052 Mil) to Dec. 2024 (円13,277 Mil).


GNI Group Common Stock Historical Data

The historical data trend for GNI Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group Common Stock Chart

GNI Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,268.47 10,884.00 10,893.07 13,052.06 13,276.70

GNI Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,052.06 13,091.37 13,218.95 13,223.62 13,276.70

GNI Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


GNI Group Business Description

Traded in Other Exchanges
Address
Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group Headlines

No Headlines